Technical Analysis for SHPH - Shuttle Pharmaceuticals Holdings, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.87 | -2.97% | -0.03 |
SHPH closed up 0.79 percent on Wednesday, November 20, 2024, on 3 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | -2.97% | |
| NR7 | Range Contraction | -2.97% | |
| Narrow Range Bar | Range Contraction | -2.97% | |
| Inside Day | Range Contraction | -2.97% | |
| Wide Bands | Range Expansion | -2.97% | |
| Oversold Stochastic | Weakness | -2.97% | |
| New 52 Week Closing Low | Bearish | -2.21% | |
| New 52 Week Low | Weakness | -2.21% | |
| Wide Bands | Range Expansion | -2.21% | |
| Down 3 Days in a Row | Weakness | -2.21% |
| Alert | Time |
|---|---|
| Possible NR7 | about 1 hour ago |
| 60 Minute Opening Range Breakdown | about 4 hours ago |
| Down 5% | about 5 hours ago |
| Down 3% | about 5 hours ago |
| Fell Below Previous Day's Low | about 5 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Radiation Radiation Therapy Sarcoma Brain Tumor Soft Tissue Sarcoma Liver Cancer
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Radiation Radiation Therapy Sarcoma Brain Tumor Soft Tissue Sarcoma Liver Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.9464 |
| 52 Week Low | 0.8338 |
| Average Volume | 1,371,049 |
| 200-Day Moving Average | 2.66 |
| 50-Day Moving Average | 1.31 |
| 20-Day Moving Average | 1.29 |
| 10-Day Moving Average | 1.05 |
| Average True Range | 0.15 |
| RSI (14) | 32.43 |
| ADX | 16.15 |
| +DI | 22.81 |
| -DI | 29.58 |
| Chandelier Exit (Long, 3 ATRs) | 1.79 |
| Chandelier Exit (Short, 3 ATRs) | 1.29 |
| Upper Bollinger Bands | 1.88 |
| Lower Bollinger Band | 0.69 |
| Percent B (%b) | 0.17 |
| BandWidth | 92.65 |
| MACD Line | -0.13 |
| MACD Signal Line | -0.08 |
| MACD Histogram | -0.0472 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.98 | ||||
| Resistance 3 (R3) | 0.98 | 0.95 | 0.97 | ||
| Resistance 2 (R2) | 0.95 | 0.93 | 0.95 | 0.97 | |
| Resistance 1 (R1) | 0.92 | 0.91 | 0.94 | 0.93 | 0.96 |
| Pivot Point | 0.89 | 0.89 | 0.90 | 0.89 | 0.89 |
| Support 1 (S1) | 0.87 | 0.87 | 0.88 | 0.87 | 0.84 |
| Support 2 (S2) | 0.84 | 0.86 | 0.84 | 0.83 | |
| Support 3 (S3) | 0.81 | 0.84 | 0.83 | ||
| Support 4 (S4) | 0.81 |
